Jan 25, 2021 8:30am EST Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA®
Jan 04, 2021 4:30pm EST Medexus Pharmaceuticals to Present at the SNN Network Canada Virtual Event on Thursday, January 7, 2021
Dec 18, 2020 8:30am EST Medexus Enters into Exclusive License to Register and Commercialize Triamcinolone Hexacetonide (TH) in the United States with Ethypharm
Dec 08, 2020 8:30am EST Medexus to Present at The 13th Annual LD Micro Main Event Conference on December 15th
Nov 16, 2020 5:15pm EST Medexus Pharmaceuticals Reports Operating and Financial Results for the Three- and Six-Month Periods Ending September 30, 2020
Nov 16, 2020 8:00am EST Medexus Reaches 50% Enrollment in IXINITY® Phase 4 Clinical Trial Targeting Label Expansion for Pediatric Hemophilia B Patients
